|Last Price||58.72||Max Price||84.00|
|Min Price||58.72||1 Year return||-5.29|
|Avg. Target||79.00||Expected Return||34.54 %|
|Annual report 2016|
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Gilead Sciences' mission is to advance the care of patients suffering from life-threatening diseases worldwide. In addition to Gilead Sciences' marketed products, Gilead Sciences has a clinical, preclinical and research pipeline focused on developing anti-infectives. Gilead Sciences’ stocks are traded in New York and the company is a component of the NASDAQ 100-index (ISIN: US3755581036/ Symbol: GILD).